Expected earnings - Lyell Immunopharma Inc.
Source: US Earnings Reports
Lyell Immunopharma Inc. (LYEL) is expected to report $-3.8 for Q2 2025
Lyell Immunopharma Inc.
NASDAQ: LYEL
LYEL Trading
-2.13% G/L:
$24.37 Last:
40,301 Volume:
$24.69 Open:
LYEL Latest News
March 12, 2026 04:05:00 pm
Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results
March 09, 2026 08:00:00 am
Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer
February 23, 2026 08:00:00 am
Lyell Immunopharma Announces Participation in March Investor Conferences
LYEL Stock Data
$503,932,654
12,184,349
0.5%
11
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
